Literature DB >> 27111390

From first-generation hepatitis C virus protease inhibitors to direct-acting antivirals: self-reported symptoms as a warning signal for potential adverse events (ANRS HC26, ANRS HC27 trials).

Fabienne Marcellin1, Isabelle Fournier, Maria P Carrieri, Isabelle Poizot-Martin, Laurent Cotte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27111390     DOI： 10.1097/MEG.0000000000000612

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN： 0954-691X            Impact factor:   2.566


× No keyword cloud information.
  2 in total

1.  Life after hepatitis C cure in HIV-infected people who inject drugs and men who have sex with men treated with direct-acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH).

Authors:  Marion Mora; Trevor Goodyear; Fabienne Marcellin; Jeannie Shoveller; Vincent Di Beo; Chiara Calzolaio; Philippe Sogni; Linda Wittkop; David Zucman; Isabelle Poizot-Martin; Karine Lacombe; Dominique Salmon-Céron; Rod Knight; Patrizia Carrieri
Journal:  J Viral Hepat       Date:  2020-09-24       Impact factor: 3.728

2.  Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial).

Authors:  Maria Patrizia Carrieri; Camelia Protopopescu; Zobair Younossi; Antoine Vilotitch; Hélène Fontaine; Ventzislava Petrov-Sanchez; Fabienne Marcellin; Fabrice Carrat; Christophe Hézode; Marc Bourlière
Journal:  Patient       Date:  2017-10       Impact factor: 3.481
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.